HLA-DR1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis
Abstract
Coronary atherosclerotic disease is one of the most endangering health disorder worldwide. This study was designed to investigate the correlation between HLA-DRβ1 alleles and circulating Th1/Th2 type cytokines in coronary atherosclerosis.
By Elisa, Th1/Th2 type cytokines were determined in serum samples of 31 subjects with unstable angina, 27 subjects with chronic stable angina and 24 individuals as normal control. By SSP-PCR, more than 100 alleles of HLA-DRB1 were typed in 24 subjects who had skewed serum levels of Th1/Th2 type cytokines. Lipid profiles were determined by the routine methods of clinical laboratory in all subjects.
The mean serum concentration of IL-10 in normal control subjects was higher in comparison to the patient groups.0.33±0.59 pg/ml versus 0.064±0.3 pg/ml in unstable angina pectoris group (p<0.028) and 0.22±0.6 pg/ml in chronic stable subjects. There was no statistically significant difference among the groups in serum levels of other desired cytokines (IFN-γ, IL-4). 33.33% of normal control subjects were HLA-DR16 positive whereas none of the subjects with chronic stable angina or individuals with unstable angina pectoris was positive for this antigen. The mean concentration of serum LDL-cholesterol in normal control group was high 142.046±35.40 (pg/ml).
This preliminary study shows that the atherogenic effect of the LDL- cholesterol may be dampened by HDL-cholesterol through anti inflammatory cytokine IL-10 and HLA-DR16, a phenomenon interpretable via immunological homunculus theory.
1. Jawien J. New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn 2008; 118(3):127-31.
2. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86 (2): 515-81.
3. Szodoray P, Timar O, Veres K, Der H, Szomjak E, Lakos G, et al. Th1/Th2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines- immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol 2006; 64(3):336-44.
4. Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK. Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000; 102(10):1114-9.
5. Ranjbaran H, Sokol SI, Gallo A, Eid RE, Iakimov AO, D'Alessio A, et al. An inflammatory pathway of IFN- gamma production in coronary atherosclerosis. J Immunol 2007; 178(1):592-604.
6. Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A, et al. Interleukin-17 and Interferon-γ are produced concomitantly by human coronary artery–infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009; 119(10):1424-32.
7. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atheroscelerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145(1):33-43.
8. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001; 104(7):746-9.
9. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996; 97 (9):2130-8.
10.Cohen IR. Peptide therapy for type 1 diabetes: the immunological homunculus and the rationale for vaccination. Diabetologia 2002; 45(10):1468-74.
11.Murray JS. How the MHC selects Th1/Th2 Immunity. Immunol Today 1998; 19(4):155-63.
12.De Palma R, Del Galdo F, Abbate G, Chiariello M, Calabro R, Forte L, et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: Evidence for a local, intracoronary immunologic mechanisms. Circulation 2006; 113(5):640-6.
13.Gonzalez-Gay MA, Gonzalez-Juanatey C, Ollier WE. Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles. Autoimmun Rev 2004; 3(4):301-4.
14.Mas A, Blanco E, Monux G, Urcelay E, Serrano FJ, De La Concha EG, et al. DRB1-TNF-α-TNF-β haplotype is strongly associated with severe aortoiliac occlusive disease, a clinical form of atherosclerosis. Hum Immunol 2005; 66(10):1062-7.
15.Rojas-Villarraga A, Ortega-Hernandez OD, Gomez LF, Pardo AL, López-Guzmán S, Arango-Ferreira C, et al. Risk factor associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Semin Arthritis Rheum 2008; 38(2):71-82.
16.Hansson GK. Cell- mediated immunity in atherosclerosis. Curr Opin Lipidol 1997; 8(5):301-11. 17.Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, et al. The Th17/ Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127(1):89-97.
18.Ohashi K, Burkart V, Flohé S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164(2):58-61.
19.Chen W, Syldath U, Bellmann K, Burkart V, Kolb H. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 1999; 162(6):3212-9.
20.Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105(10):1158-61. 21.Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta - cell function in new-onset type 1 diabetes and immunomodulation with a heat shock protein peptide (Diapep 277): a randomised, double–blind, phase II trial. Lancet 2001; 358(9295):1749-53.
22.Dahlen GH, Slunga L, Lindblom B. Importance of LP(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes. Clin Genet 1994; 46(1spec No):46-51.
23.Jonasson L, Eriksson T, Dahle'n GH, Lindblom B. Lipoprotein(a) and HLA-DRB1 and –DQB1 genes in coronary artery disease. Atherosclerosis 1997; 133(1):111-4.
24.Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-porrua C, Miranda-Fillory JA, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57(1):125-32. 25.Palikhe A, Lokki ML, Saikku P, Leinonen M, Paldanius M, Seppanen M, et al. Association of Chlamydia pneumoniae infection with HLA-B∗35 in patients with coronary artery disease.Clini Vaccine immunol 2008;15(1):55-9.
26.Schumann J, De Libero G. Serum lipoproteins: Trojan horses of the immune response? Trends Immunol 2006;27(2):57-9.
Files | ||
Issue | Vol 10, No 1 (2011) | |
Section | Articles | |
Keywords | ||
Cholesterol Coronary Atherosclerosis Cytokine HLA-DR1 Antigen Th1 Cells Th2 Cells |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |